Cortex (Cor) [formerly CORX] Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cortex (Cor) [formerly CORX]

COR 362.22

+0.8%

12:45 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: GR who wrote (530)	10/18/1998 3:40:00 PM
From: lloyd bashaw	Read Replies (1) of 1255

GR: You are correct. There is risk. At this price when the partner is announced; however, it could be a double or triple (200 to 300% gain). Risk/Reward Three human clinical safety studies have now been completed with CX516 ("AMPALEX"). In all three studies, CX516 was safe and well-tolerated on acute oral administration and, importantly, statistically-significant positive effects on memory performance were seen in healthy volunteers. I believe there is a reason for this NBC National news spot at this time.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next